Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients

Aim: This study aimed to report the efficacy and safety of trans-arterial chemoembolization (TACE) plus lenvatinib and camrelizumab in patients with advanced hepatocellular carcinoma (HCC). Methods: This retrospective study enrolled 22 patients with advanced HCC from March 2018 to December 2019. All...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Juanfang, Li, Zhen, Zhang, Wenguang, Lu, Huibin, Sun, Zhanguo, Wang, Guozheng, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558352/
https://www.ncbi.nlm.nih.gov/pubmed/34733154
http://dx.doi.org/10.3389/fphar.2021.709060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558352/
https://www.ncbi.nlm.nih.gov/pubmed/34733154
http://dx.doi.org/10.3389/fphar.2021.709060

Ejemplares similares